Literature DB >> 16006482

Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains.

Pedro Faisca1, Dao Bui Tran Anh, Daniel J-M Desmecht.   

Abstract

The Paramyxoviridae family includes some of the most important and ubiquitous disease-causing viruses of infants and children, most of which cause significant infections of the respiratory tract. Evidence is accumulating in humans that genetic factors are involved in the severity of clinical presentation. As a first step toward the identification of the genes involved, this study was undertaken to establish whether laboratory mouse strains differ in susceptibility to Sendai virus, the murine counterpart of human type-1 parainfluenza virus which, historically, has been used extensively in studies that have defined the basic biological properties of paramyxoviruses in general. With this purpose in mind, double-chamber plethysmography data were collected daily for 7 days after inoculation of Sendai virus in six inbred strains of mice. In parallel, histological examinations and lung viral titration were carried out from day 5 to day 7 after inoculation. Pulmonary structure/function values closely reflected the success of viral replication in the lungs and revealed a pattern of continuous variation with resistant, intermediate, and susceptible strains. The results unambiguously suggest that BALB/c (resistant) and 129Sv (susceptible) strains should be used in crossing experiments aimed at identifying the genes involved in resistance to Paramyxoviridae by the positional cloning approach.

Entities:  

Mesh:

Year:  2005        PMID: 16006482     DOI: 10.1152/ajplung.00240.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Authors:  Makiko Watanabe; Vasiliy P Mishin; Scott A Brown; Charles J Russell; Kelli Boyd; Y Sudhakara Babu; Garry Taylor; Xiaoping Xiong; Xiaowei Yan; Allen Portner; Irina V Alymova
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.

Authors:  Laura E Luque; Olga A Bridges; John N Mason; Kelli L Boyd; Allen Portner; Charles J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 3.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  Modulating mouse innate immunity to RNA viruses by expressing the Bos taurus Mx system.

Authors:  M-M Garigliany; K Cloquette; M Leroy; A Decreux; N Goris; K De Clercq; D Desmecht
Journal:  Transgenic Res       Date:  2009-04-23       Impact factor: 2.788

5.  Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.

Authors:  John N Mason; Husni Elbahesh; Charles J Russell
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

6.  Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Authors:  Crystal W Burke; John N Mason; Sherri L Surman; Bart G Jones; Emilie Dalloneau; Julia L Hurwitz; Charles J Russell
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823

7.  Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice.

Authors:  Mutien Marie Garigliany; Adélite Habyarimana; Bénédicte Lambrecht; Els Van de Paar; Anne Cornet; Thierry van den Berg; Daniel Desmecht
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

Review 8.  Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses.

Authors:  Charles J Russell; Julia L Hurwitz
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.